Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12134-12145

  Lara, Estelle ^a   Billecocq, Agnès ^a   Leger, Psylvia ^a   Bouloy, Michèle ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SPACER DNA; TRANSCRIPTASE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE DELETION; GENETIC VARIABILITY; KIDNEY CELL; MOLECULAR RECOGNITION; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MOTIF; RIBOSOME; RIFT VALLEY FEVER BUNYAVIRUS; SIGNAL TRANSDUCTION; STOP CODON; TRANSCRIPTION TERMINATION; VERO CELL; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION; VIRUS RECOMBINANT; WILD TYPE;

AFRICA; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CERCOPITHECUS AETHIOPS; DNA, INTERGENIC; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; RNA, MESSENGER; RNA, VIRAL; SEQUENCE HOMOLOGY, NUCLEIC ACID; TERMINATOR REGIONS, GENETIC; TRANSCRIPTION, GENETIC; VERO CELLS;

AVES; PHLEBOVIRUS; RIFT VALLEY FEVER VIRUS; VIRUSES;

EID: 81255123539     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05322-11     Document Type: Article

References (37)

1. Albarino, C. G., B. H. Bird, and S. T. Nichol. 2007. A shared transcription termination signal on negative and ambisense RNA genome segments of Rift Valley fever, sandfly fever Sicilian, and Toscana viruses. J. Virol. 81: 5246-5256.
2. Andriamandimby, S. F., et al. 2010. Rift Valley fever during rainy seasons, Madagascar, 2008 and 2009. Emerg. Infect. Dis. 16:963-970.
3. Anyangu, A. S., et al. 2010. Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am. J. Trop. Med. Hyg. 83:14-21.
4. Barr, J. N. 2007. Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination. RNA 13:731-736.
5. Barr, J. N., J. W. Rodgers, and G. W. Wertz. 2006. Identification of the Bunyamwera bunyavirus transcription termination signal. J. Gen. Virol. 87: 189-198.
6. Bellocq, C., and D. Kolakofsky. 1987. Translational requirement for La Crosse virus S-mRNA synthesis: a possible mechanism. J. Virol. 61:3960-3967.
7. Billecocq, A., et al. 2008. RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology 378:377-384.
8. Bird, B. H., M. L. Khristova, P. E. Rollin, T. G. Ksiazek, and S. T. Nichol. 2007. Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J. Virol. 81:2805-2816.
9. Bouloy, M., and R. Flick. 2009. Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. Antiviral Res. 84:101-118.
10. Collett, M. S. 1986. Messenger RNA of the M segment RNA of Rift Valley fever virus. Virology 151:151-156.
11. Daubney, R. J., J. R. Hudson, and P. C. Garnham. 1931. Enzootic hepatitis of Rift Valley fever. An underdescribed virus disease of sheep, cattle and man from East Africa. J. Pathol. Bacteriol. 34:545-579.
12. Edmonds, M. 2002. A history of poly A sequences: from formation to factors to function. Prog. Nucleic Acid Res. Mol. Biol. 71:285-389.
13. Emery, V. C., and D. H. L. Bishop. 1987. Characterization of Punta Toro S mRNA species and identification of an inverted complementary sequence in the intergenic region of Punta Toro phlebovirus ambisense S RNA that is involved in mRNA transcription termination. Virology 156:1-11.
14. Gauliard, N., A. Billecocq, R. Flick, and M. Bouloy. 2006. Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis. Virology 351:170-179.
15. Giorgi, C., et al. 1991. Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian sandfly fever, and Uukuniemi viruses. Virology 180:738-753.
16. Gro, M. C., P. Di Bonito, L. Accardi, and C. Giorgi. 1992. Analysis of 3′ and 5′ ends of N and NSs messenger RNAs of Toscana phlebovirus. Virology 191:435-438.
17. Habjan, M., et al. 2008. Processing of genome 5′ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 3:e2032.
18. Hutchinson, K. L., C. J. Peters, and S. T. Nichol. 1996. Sin Nombre virus mRNA synthesis. Virology 224:139-149.
19. Ihara, T., Y. Matsuura, and D. H. Bishop. 1985. Analyses of the mRNA transcription processes of Punta Toro phlebovirus (Bunyaviridae). Virology 147:317-325.
20. Ikegami, T., S. Won, C. J. Peters, and S. Makino. 2007. Characterization of Rift Valley fever virus transcriptional terminations. J. Virol. 81:8421-8438.
21. Ikegami, T., S. Won, C. J. Peters, and S. Makino. 2005. Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J. Virol. 79:12106-12111.
22. Ito, N., et al. 2003. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol. Immunol. 47:613-617.
23. LaBeaud, A. D., J. W. Kazura, and C. H. King. 2010. Advances in Rift Valley fever research: insights for disease prevention. Curr. Opin. Infect. Dis. 23: 403-408.
24. LaBeaud, A. D., et al. 2008. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya. Emerg. Infect. Dis. 14:1240-1246.
25. Lopez, N., and M. T. Franze-Fernandez. 2007. A single stem-loop structure in Tacaribe arenavirus intergenic region is essential for transcription termination but is not required for a correct initiation of transcription and replication. Virus Res. 124:237-244.
26. Meegan, J. M., and C. J. Bailey. 1988. Rift Valley fever, vol. IV. CRC Press Inc., Boca Raton, FL.
27. Mohamed, M., et al. 2010. Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am. J. Trop. Med. Hyg. 83: 22-27.
28. Nichol, S. T., et al. 2005. The Bunyaviridae, p. 695-716. In C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy. Classification and nomenclature of viruses. Eighth report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, London, United Kingdom.
29. Pepin, M., M. Bouloy, B. H. Bird, A. Kemp, and J. Paweska. 2010. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 41:61.
30. Pinschewer, D. D., M. Perez, and J. C. de la Torre. 2005. Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J. Virol. 79:4519-4526.
31. Reguera, J., F. Weber, and S. Cusack. 2010. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog. 6:e1001101.
32. Simons, J. F., and R. F. Pettersson. 1991. Host-derived 5′ ends and overlapping complementary 3′ ends of the two mRNAs transcribed from the ambisense S segment of Uukuniemi virus. J. Virol. 65:4741-4748.
33. Sissoko, D., et al. 2009. Rift Valley fever, Mayotte, 2007-2008. Emerg. Infect. Dis. 15:568-570.
34. Swanepoel, R., and J. A. W. Coetzer. 2004. Rift Valley fever, p. 1037-1070. In J. Coetzer and R. Tustin (ed.), Infectious diseases of livestock, vol. 2. Oxford University Press, Cape Town, South Africa.
35. van Knippenberg, I., R. Goldbach, and R. Kormelink. 2005. Tomato spotted wilt virus S-segment mRNAs have overlapping 3′-ends containing a predicted stem-loop structure and conserved sequence motif. Virus Res. 110: 125-131.
36. Vialat, P., and M. Bouloy. 1992. Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs. J. Virol. 66:685-693.
37. Zamoto-Niikura, A., K. Terasaki, T. Ikegami, C. J. Peters, and S. Makino. 2009. Rift Valley fever virus L protein forms a biologically active oligomer. J. Virol. 83:12779-12789.